Carefully read the submission guidelines as follows:

1. Manuscripts

We invite theoretical, methodological, applied, and empirical articles exploring the study of Clinical and Pharmaceuticial Sciences, representing various methodological traditions (quantitative, qualitative, mixed methods) and disciplines (psychology, education, sociology, anthropology, philosophy of Health, etc.). Regardless of the type of article, methodological tradition, or disciplinary perspective, authors are expected to situate their work in the existing literature.

 2. Types of Paper

Full-length articles provide the main content of the journal. Each should demonstrate a significant contribution to knowledge related to future studies. Papers should demonstrate rigorous approaches to research and new knowledge creation, be well organized, and be written in clear English. The style of the paper can be as a research article or as an essay demonstrating critical reasoning, scholarship, and a clear contribution to knowledge in the field. The recommended length of articles is around 8,000 words (range of 6,000-10,000), giving sufficient space for a rigorous approach without superfluous material.

 3. References

Increased discoverability of research and high-quality peer review are ensured by online links to the sources cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, Crossref, and PubMed, please ensure that the data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication years, and pagination may prevent link creation. When copying references, please be careful as they may already contain errors. Use of the DOI is highly encouraged. A DOI is guaranteed never to change, so you can use it as a permanent link to any electronic article. Please note the format of such citations should be in the same style as all other references in the paper.

4. Expectations for Authors

Prior to submitting an article, please make sure that your article is (a) adequately situated in the Clinical and Pharmaceuticial Sciences studies literature, (b) meets the appropriate word limit, (c) has been carefully proofread, and (d) adheres to IEEE Style. All work must be original and cannot have been published or be under review elsewhere. Portions of text that are identical or near-identical to previously published work by authors should be properly noted and cited and if necessary, permission to reproduce the text from the publisher needs to be obtained in advance of submitting the article.

5. Data Visualization

To enhance reader engagement with your research, consider incorporating at least two interactive data visualizations in your publication. Follow the instructions here to find out about available data visualization options and how to include them with your article.

6. Stylistic Conventions

All articles are expected to adhere to the stylistic conventions of IEEE Style. Articles should conform to the standards of spelling, grammar, and punctuation for British English and will be converted accordingly during the editorial process.

 7.Review Process

Once a manuscript has been submitted, it will undergo a preliminary review from the managing editor (to assess fit and adherence to the journal’s guidelines). The paper will then be assigned to the editor and an associate editor who will provide an additional assessment of fit. Papers that fail to adhere to the journal’s guidelines or lack fit based on the preliminary review of the editor and/or associate editor will be rejected. If a paper passes preliminary review, it will then be assigned to at least two reviewers for double-blind review. Authors invited to engage in a revision will be provided with 30 days to submit their revision; otherwise, the paper may be automatically rejected. Authors can request an extension from the Associate Editor managing the paper. If a final decision (accept/reject) has not been made after the first round, a final decision (accept/reject) will be rendered after the second round.

8.Authorship

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

 9.Changes to authorship

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion, or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in the author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal, or rearrangement. In the case of the addition or removal of authors, this includes confirmation from the author being added or removed. Only in exceptional circumstances will the Editor consider the addition, deletion, or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

10. Role of the funding source

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design, in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement, it is recommended to state this.

11. Corrections and Final Copy

If the manuscript is accepted for publication, a copy of the final form of the paper in PDF is requested. Corrections should be clearly identified and returned within five working days of receipt. Major alterations cannot be accepted. The author is required to submit a statement that the submitted paper has not been published or approved for publishing elsewhere. The editors will not return submitted materials to the authors. The authors will not receive gratification for publishing their papers. Papers that do not fulfill basic linguistic correctness requirements will not be accepted.

 12. General Requirements

The minimum standard requirements of Clinical and Pharmaceutical Sciences Journal must be

1. Written in English.
2. The length of the submitted paper is at least sixpages and no more than 20 pages. Editors will evaluate if an article is needing more than 20 pages.
3. Use a tool such as Zotero, Mendeley, or EndNote for reference management and formatting, and chooseIEEE Style.
4. Make sure that your paper is prepared using the CliPs paper template.

13. Structure of The Manuscript

The manuscript must be qualified and suggested present follow the structure:

• The title of the paper should describe the research aims, method/model, and objective without an Acronym or abbreviation. Please provide a title that is concise and informative; ideally, it should contain no more than 20 words. Titles are often used in information-retrieval systems, so please keep in mind that your choice of title may impact how easily readers can discover your article.
• Keywords. Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
• The abstract of your paper is a critical part of your manuscript; it plays a central role in the review process. The Abstract has a maximum of 250 WORDS; No citation. State in the abstract a primary goal, research design, methodology, main outcomes and results, and conclusions.
• Section structure. Authors are suggested to present their articles in the section structure:Introduction - Method - Results and Discussion – Conclusion - Acknowledgments – References.

• Introduction: State the objectives of the work and provide an adequate background to explain the purpose and context, avoiding a detailed literature survey or a summary of the results. Provide a section that identifies how the work of the study relates to previous research studies and literature. This might be shown as a separate section or as part of the introduction or methodology, depending on the nature of the study. It is important to demonstrate the contribution made by the study to future studies' knowledge and, hence the way in which it builds on or adds to previous work on the particular topic. In the case of Experimental Futures," the approach will depend on how changes in practice represented in the paper are conceptualized. The background literature can provide a basis for the conceptualization, for example, social structure, work, human experiences, socio-technological trends, design thinking, etc. In short communications, reference to previous research should be used to support the claims being made in the paper.
• Method: Explain the conceptual basis of the research study, essay, or review and how it fits with the research questions and objectives of the study. Show how the methods used relate to this and what was done to generate new knowledge in a rigorous way. In the case of Experimental Futures describe and explain the practices identified and how these practices are created (for instance, what is done, what technologies are used, what eco-system is involved). Explain how the practices have been sustained over time and have evolved from an idea or design to a practice. Make clear what is distinctive and 'new' about these practices. The tone of the paper should be critical reasoning and not advocacy.
• Results and Discussion: Results of future research or foresight studies should be clear and concise. This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Demonstrate how the work reported in the paper, essay, or review contributes new knowledge. Show how the work links with existing literature, including future studies literature, avoiding over-elaborate citations. With regard to Experimental Futures, the discussion should explore the significance of the case. Typical questions might include: Why is it important? What alternative futures are envisaged or imagined from this case? What trends in societies might be driven or altered by it? What unintended consequences might be identified at this stage?
• Conclusion: A brief explanation of the significance and implications of the work reported
• Acknowledgments: Collate acknowledgments in a separate section at the end of the article before the references and do not, therefore, include them on the title page as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance proofreading the article, etc.). Any individuals who contributed to the manuscript but did not meet the authorship's necessary criteria should be acknowledged. Acknowledgments should be limited to those who helped extensively, such as providing statistical help, essential equipment, or translating references.
• References. Expect a minimum of30 references, primarily with a minimum of 80% to international journal papers from Science Direct or indexed by Scopus Database, and choose IEEE style. Please don't use unpredictable website sources. The use of DOI is highly encouraged